A recent study found that lncRNA MALAT1 was overexpressed in LSCC tissues and highly correlated with the 5‐year survival of patients; it triggers the resistance of LSCC to chemotherapy drugs by promoting metastasis and inhibiting tumor cell apoptosis.13 The gene discussed is MALAT1; the disease is neoplasm.